Posts tagged “N.C. Biotech Center”
The state-run program provides matching grants of up to $50,000 to North Carolina businesses that have received either federal Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) grant awards.
Cardioxyl Pharmaceuticals and Bristol-Myers Squibb have signed an agreement under which Bristol-Myers Squibb will acquire Cardioxyl and its assets in potential $2 billion deal.
Every year an estimated 3 to 5 million sharks are slaughtered for a precious omega-2 oil in their livers called squalene, a clear liquid, lighter than water, that helps them float. SynShark, which has operations in NC, wants to harvest squalene from the leaves of tobacco plants that have been genetically engineered to synthesize the oil.
NCBIO, the trade organization for North Carolina biotechnology companies, expects about 200 to 250 at its annual meeting at the NC Biotechnology Center Thursday. Sam Taylor, NCBIO president, said that in addition to two key note speakers, the event includes a review of state and federal policies related to biotech, including what the NC legislature did this year.
Humacyte, a Duke University regenerative medicine spinout, has raised $150 million committed Series B preferred stock financing. The privately held company's new round of financing, led by a global consortium of new and existing private investors, is among the largest such infusions in the annals of life science company development.
A crab and lobster bait that looks like a popular dessert, an oyster bed that disappears when the oysters do - are some of the ideas pitched to investors at the BioMarine Business Conference in Wilimington.
The 2015 BioMarine Business Convention in Wilmington closed Wednesday with a landmark agreement of cooperation between North Carolina's Marine Bio-Technologies Center of Innovation (MBCOI) and the government of Quebec, Canada.
(L to R) Louise Fortin, director of the Quebec Trade Office in Atlanta, Dr. Deborah Mosca, CEO of MBCOI, and Associate General Secretary Georges Farrah of the Secretariat aux Affaires Maritimes, Quebec.
The 2015 BioMarine international conference kicked off in Wilmington Monday evening with a well-attended invite-only networking event aboard the Battleship North Carolina, moored across the Cape Fear River from downtown Wilmington. Refreshments included an array of sustainably produced North Carolina seafood products and local craft beers, as well as the ubiquitous NC barbecue and cornbread. The Marine Bio-Technologies Center of Innovation and the North Carolina Biotechnology Center co-hosted the event.
North Carolina has been seeing a lot of recent rewards for its long-term investment in the life sciences. The recently released CED Innovators Report shows life science companies nailed down more than $268 million in equity investment in the first half of 2015.
The BioMarine Convention of company leaders, investors, and government leaders focused on business deal-making in the diverse marine biotech market space is set to start at the Southeastern North Carolina Biotechnology Center Tuesday and Wednesday.
Carolina Liquid Chemistries (CLC), a Winston-Salem company that makes laboratory diagnostics and testing systems, has received FDA clearance to sell its latest state-of-the-art chemistry analyzer for hospital and clinical use.
Welcome home, Icagen. Well, actually, the Durham drug development company never completely left, but now its once-relocated headquarters is returning to North Carolina from the Boston area with one relocating employee, bringing the head count at its Emperor Boulevard site to 20.
When Ben Bahr, Ph.D., was recruited to the University of North Carolina at Pembroke in 2009 as the inaugural William C. Friday Distinguished Chair and Professor of Molecular Biology and Biochemistry, much was expected. The newly created position was charged with advancing biotechnology research and education at the university and spurring economic development in southeastern North Carolina.
NovaTarg, a biotech company developing new treatments for cancer, kidney disease and diabetes, has received $3.2 million in Small Business Innovative Research grants, tripling the firm's current funding.
Five North Carolina companies developing marine-oriented technologies are among 15 from around the world that are scheduled to meet with possible investors and partners during an international convention co-hosted by the North Carolina Biotechnology Center.
The North Carolina legislature has passed a $21.74 billion budget Gov. Pat McCrory says he will sign it today (Friday). The 429-page billl reduces personal income tax rates, fails to renew the 35 percent renewable energy tax break, and continues funding the NC Biotechnology Center at $13.6 million, despite being targeted for a cut earlier, and creates a "venture capital multiplier fund."
- Google to buy solar power from Duke Energy for NC data center
- US economy grew at 2.1 percent rate in third quarter
- Local business booted out by second phase of Hillsborough Street project
- US home prices jump in September by most in more than a year
- NC's chief information officer returning to private sector